The selectivity and conversion of the sulfuric acid-catalyzed Beckmann rearrangement of cyclohexanone oxime, dissolved in cyclooctane, to e-caprolactam are determined in a microreactor for conditions with a high concentration of e-caprolactam. The microreactor consists of a low-temperature mixing zone followed by a high-temperature reaction zone. The mixing is conducted in a splitand-recombine micromixer and a microchannel at 65°C, followed immediately by a second microchannel at 100-127°C to obtain complete conversion. Under these conditions a selectivity of 99 % is achieved. The residence time of the reactants in the microreactor setup is about 10 s. In literature, a selectivity of about 95 % for the same reaction in a similar setup is reported, but at a uniform temperature of 120-130°C for mixing and reaction. So, suppressing the reaction during mixing is a major tool to enhance the selectivity to e-caprolactam.
Beckmann rearrangement of cyclohexanone oxime dissolved in cyclooctane with oleum to ϵ‐caprolactam was demonstrated in a microreactor setup with internal recirculation operated in continuous mode. The core of the setup comprised a 316 stainless‐steel micromixer consisting of 17 split‐and‐recombine units connected to a delay loop, a 316 stainless‐steel microchannel reactor with an internal diameter of 0.250 mm and a length of 0.50 m. At 100 °C, the conversion of cyclohexanone oxime was complete and the selectivity towards ϵ‐caprolactam was approximately 99 %. The solvent cyclooctane reduces the observed purity of the produced oleum/ϵ‐caprolactam. This reduction in purity might be a severe hurdle for usage of a solvent on the industrial scale in the Beckmann rearrangement of cyclohexanone oxime in oleum to ϵ‐caprolactam.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.